Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-2287-2019 — ARIES C. difficile Assay , REF 50-10018, UDI # 00840487100059

U.S. FDA — Device Enforcement · United States · 2019-02-20 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-2287-2019
Date of alert
2019-02-20
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Luminex Corporation
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
00840487100059
Reported risk: Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.